Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension

American Journal of Health-System Pharmacy

Volumn 64, Issue 18, 2007, Pages 1955-1961

  De Souza, Walnéia Aparecida ^a,b   Yugar Toledo, Juan Carlos ^c   Bergsten Mendes, Gun ^d   Sabha, Maricene ^c   Moreno Jr , Heitor ^b  

^a FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c Department of Pharmacology   (Saudi Arabia)

^d Department of Pharmacology ^*  (Brazil)

Author keywords

Ambulatory care; Compliance; Data collection; Hospitals; Hypertension; Interventions; Patients; Pharmaceutical care; Pharmacists; Quality of life; Toxicity

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CARVEDILOL; CHLORTALIDONE; CLOPAMIDE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LERCANIDIPINE; LISINOPRIL; LOSARTAN; MANIDIPINE; METOPROLOL; NIFEDIPINE; PINDOLOL; PROPRANOLOL; RAMIPRIL; SPIRONOLACTONE; TELMISARTAN; UNINDEXED DRUG; VERAPAMIL;

ADULT; AGED; AMBULATORY CARE; ANTIHYPERTENSIVE THERAPY; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; BRAZIL; CLINICAL ARTICLE; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACEUTICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; SOCIAL INTERACTION; ADOLESCENT; BLOOD PRESSURE; DRUG EFFECT; FOLLOW UP; HEALTH STATUS; MIDDLE AGED; PHARMACY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHARMACEUTICAL SERVICES; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 34548715921     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060547     Document Type: Article

References (30)

1. Burt VL, Cutler JA, Higgins M et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension. 1995; 26:60-9.
2. Oparil S, Calhoun DA. Managing the patient with hard-to-control hypertension. Am Fam Physician. 1998; 57:1007-14.
3. Côté I, Moisan J, Chabot I et al. Health-related quality of life in hypertension: impact of pharmacy intervention programme. J Clin Pharm Ther. 2005; 30:355-62.
4. IV Brazilian guidelines in arterial hypertension. Arq Bras Cardiol. 2004; 82(suppl 4):7-22.
5. Fuchs FD, Moreira LB, Moraes RS et al. [Prevalence of systemic arterial hypertension and associated risk factors in the Porto Alegre metropolitan area. Populational-based study.] Arq Bras Cardiol. 1994; 63:473-9. In Portuguese.
6. Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003; 289:2560-72.
7. Burnier M, Santschi V, Favrat B et al. Monitoring compliance in resistant hypertension: an important step in patient management. J Hypertens. 2003; 21(suppl 2):S37-42.
8. Cittadino M, Gonçalves De Sousa M, Ugar-Toledo JC et al. Biochemical endothelial markers and cardiovascular remodeling in refractory arterial hypertension. Clin Exp Hypertens. 2003; 25: 25-33.
9. Williams GH. Assessing patient wellness: new perspectives on quality of life and compliance. Am J Hypertens. 1998; 11:186S-91S.
10. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47:533-43.
11. Park JJ, Kelly P, Carter BL et al. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc. 1996; 36:443-51.
12. McKenney JM, Slining JM, Henderson HR et al. The effect of clinical pharmacy services on patients with essential hypertension. Circulation. 1973; 48:1104-11.
13. Carter BL, Elliott WJ. The role of pharmacists in the detection, management, and control of hypertension: a national call to action. Pharmacotherapy. 2000; 20:119-22.
14. Berenguer B, La Casa C, De La Matta MJ et al. Pharmaceutical care: past, present and future. Curr Pharm Des. 2004; 10:3931-46.
15. Strelec MA, Pierin AM, Mion D. The influence of patient's consciousness regarding high blood pressure and patient's attitude in face of disease controlling medicine intake. Arq Bras Cardiol. 2003; 81:349-54.
16. Litt IF, Cuskey WR. Compliance with medical regimens during adolescence. Pediatr Clin North Am. 1980; 27:3-15.
17. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30:473-83.
18. McHorney CA, Ware JE, Lu JF et al. The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994; 32:40-66.
19. Malone DC, Carter BL, Billups SJ et al. Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems? Med Care. 2001; 39:113-22.
20. Anderson RT, Hogan P, Appel L et al. Baseline correlates with quality of life among men and women with medication-controlled hypertension. The trial of nonpharmacologic interventions in the elderly (TONE). J Am Geriatr Soc. 1997; 45:1080-5.
21. Machuca M, Fernández-Llimós F, Faus MJ. Método Dáder: a guide for pharmacotherapeutic intervention. Granada, Spain: Universidad de Granada; 2003.
22. Oparil S. Are there meaningful differences in blood pressure control with current antihypertensive agents? Am J Hypertens. 2002; 15(1 pt 2):14S-21S.
23. Carter BL, Barnette DJ, Chrischilles E et al. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy. 1997; 17:1274-85.
24. Bernsten C, Björkman I, Caramona M et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care. Drugs Aging. 2001; 18:63-77.
25. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc. 2000; 40:157-65.
26. Hanlon JT, Artz MB. Drug-related problems and pharmaceutical care: what are they, do they matter, and what's next? Med Care. 2001; 39:109-12.
27. Carter BL, Zillich AJ, Elliott WJ. How pharmacists can assist physicians with controlling blood pressure. J Clin Hypertens. 2003; 5:31-7.
28. Varma S, McElnay JC, Hughes CM et al. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy. 1999; 19:860-9.
29. Volume CI, Farris KB, Kassam R et al. Pharmaceutical care research and education project: patient outcomes. J Am Pharm Assoc. 2001; 41:411-20.
30. Bernheim JL. How to get serious answers to the serious question: "How have you been?": subjective quality of life (QOL) as an individual experiential emergent construct. Bioethics. 1999; 13: 272-87.